Optibrium - Optibrium creates elegant software solutions for small molecule design, optimisation and data analysis

Skip to the content

In the News:

Optibrium Enters Cheminformatics Collaboration with
MSD, tradename of Merck & Co., Inc, USA more >

View Our Latest Webinar:

Predicting Pharmacokinetic Parameters and Curves.
Collaboration with AstraZeneca and Intellegens. view >

Data Imputation through Deep Learning by Matt Segall
Predicting Reactivity to Drug Metabolism: Beyond P450s – Modelling FMOs and UGTs by Mario Öeren
Advances in the Study of Drug Metabolism by Matt Segall

Copyright © 2020 Optibrium, Ltd. All Rights Reserved.
Optibrium™, StarDrop™, Augmented Chemistry™, Cerella™, Ocura™, Glowing Molecule™, WhichP450™, Auto-Modeller™, Nova™, MPO Explorer™ and Card View® are trademarks of Optibrium Ltd. Card View® is registered only in the United States. Matsy™ is a trademark of NextMove Software Ltd., BIOSTER™ is a trademark of iKem Szolgáltató és Kereskedelmi BT, Derek Nexus™ is a trademark of Lhasa Ltd., torch3D™ is a trademark of Cresset BioMolecular Discovery Ltd., and SeeSAR™ is a trademark of BioSolveIT GmbH.
US Patent Numbers 9,224,098 and 9,367,812

In the News:

Optibrium Enters Cheminformatics Collaboration with MSD, tradename of Merck & Co., Inc, USA more >

View Our Latest Webinar:

Predicting Pharmacokinetic Parameters and Curves.Collaboration with AstraZeneca and Intellegens. view >

Optibrium Enters Cheminformatics Collaboration with
MSD, tradename of Merck & Co., Inc, USA more >

Predicting Pharmacokinetic Parameters and Curves.
Collaboration with AstraZeneca and Intellegens. view >